US20180127814A1 - Nucleic acid detection method and assay kit - Google Patents
Nucleic acid detection method and assay kit Download PDFInfo
- Publication number
- US20180127814A1 US20180127814A1 US15/691,337 US201715691337A US2018127814A1 US 20180127814 A1 US20180127814 A1 US 20180127814A1 US 201715691337 A US201715691337 A US 201715691337A US 2018127814 A1 US2018127814 A1 US 2018127814A1
- Authority
- US
- United States
- Prior art keywords
- reaction
- amplification
- nucleic acid
- target nucleic
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 98
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 97
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 97
- 238000003149 assay kit Methods 0.000 title claims description 15
- 238000001514 detection method Methods 0.000 title description 33
- 238000006243 chemical reaction Methods 0.000 claims abstract description 125
- 230000003321 amplification Effects 0.000 claims abstract description 120
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 120
- 239000011541 reaction mixture Substances 0.000 claims abstract description 79
- 239000000523 sample Substances 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 39
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 claims abstract description 16
- 108090000790 Enzymes Proteins 0.000 claims abstract description 16
- 230000033116 oxidation-reduction process Effects 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims description 41
- 239000004615 ingredient Substances 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 9
- 230000000295 complement effect Effects 0.000 claims description 8
- 229910052737 gold Inorganic materials 0.000 claims description 7
- 239000010931 gold Substances 0.000 claims description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 5
- 238000011901 isothermal amplification Methods 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
- 239000011651 chromium Substances 0.000 claims description 3
- 239000010949 copper Substances 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 239000010948 rhodium Substances 0.000 claims description 3
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 2
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 229910052793 cadmium Inorganic materials 0.000 claims description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims description 2
- 229910052804 chromium Inorganic materials 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- 239000010941 cobalt Substances 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- 229910052802 copper Inorganic materials 0.000 claims description 2
- 239000013078 crystal Substances 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000058 cyclopentadienyl group Chemical group C1(=CC=CC1)* 0.000 claims description 2
- ZSWFCLXCOIISFI-UHFFFAOYSA-N endo-cyclopentadiene Natural products C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052736 halogen Inorganic materials 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- ASHIMQWYHVWELN-UHFFFAOYSA-N hexan-1-amine;ruthenium Chemical group [Ru].CCCCCCN ASHIMQWYHVWELN-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 2
- SHXOKQKTZJXHHR-UHFFFAOYSA-N n,n-diethyl-5-iminobenzo[a]phenoxazin-9-amine;hydrochloride Chemical compound [Cl-].C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=[NH2+])C2=C1 SHXOKQKTZJXHHR-UHFFFAOYSA-N 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- 229910052762 osmium Inorganic materials 0.000 claims description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 229910052707 ruthenium Inorganic materials 0.000 claims description 2
- 229910052709 silver Inorganic materials 0.000 claims description 2
- 239000004332 silver Substances 0.000 claims description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000011701 zinc Substances 0.000 claims 1
- 239000000047 product Substances 0.000 description 38
- 241000125945 Protoparvovirus Species 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 14
- 238000010586 diagram Methods 0.000 description 12
- 230000009467 reduction Effects 0.000 description 10
- XZTWHWHGBBCSMX-UHFFFAOYSA-J dimagnesium;phosphonato phosphate Chemical compound [Mg+2].[Mg+2].[O-]P([O-])(=O)OP([O-])([O-])=O XZTWHWHGBBCSMX-UHFFFAOYSA-J 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 8
- 238000011088 calibration curve Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000010839 reverse transcription Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- AKIZPWSPNKVOMT-UHFFFAOYSA-N 1-sulfanylhexan-1-ol Chemical compound CCCCCC(O)S AKIZPWSPNKVOMT-UHFFFAOYSA-N 0.000 description 3
- 102100034343 Integrase Human genes 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000004502 linear sweep voltammetry Methods 0.000 description 3
- 229940005657 pyrophosphoric acid Drugs 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000004365 square wave voltammetry Methods 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- QENHCSSJTJWZAL-UHFFFAOYSA-N magnesium sulfide Chemical compound [Mg+2].[S-2] QENHCSSJTJWZAL-UHFFFAOYSA-N 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000005297 pyrex Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 235000011178 triphosphate Nutrition 0.000 description 2
- 239000001226 triphosphate Substances 0.000 description 2
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 101150037646 VP gene Proteins 0.000 description 1
- -1 above Chemical class 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 238000011840 criminal investigation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000005447 environmental material Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6823—Release of bound markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/301—Hairpin oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2527/00—Reactions demanding special reaction conditions
- C12Q2527/101—Temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/137—Reactions characterised by the reaction format or use of a specific feature the purpose or use of a displacement step
- C12Q2537/1373—Displacement by a nucleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/163—Reactions characterised by the reaction format or use of a specific feature the purpose or use of blocking probe
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/113—Nucleic acid detection characterized by the use of physical, structural and functional properties the label being electroactive, e.g. redox labels
Definitions
- Embodiments described herein relate generally to a nucleic acid detection method and an assay kit.
- the nucleic acid testing is carried out in various scenes, such as clinical diagnosis and criminal investigations.
- the target genes are detected or quantified by methods such as the real-time PCR method or microarray method.
- the real-time PCR method is accompanied by the amplification of nucleic acid, and therefore its sensitivity is high and the quantitative range is wide.
- the microarray method it is possible to detect tens of thousands or more kinds of target genes simultaneously. Further, a detection method which combines these methods has been proposed.
- FIG. 1 is a flowchart showing an example of a nucleic acid detection method in an embodiment.
- FIG. 2 is a diagram showing an example of a substrate of the embodiment.
- FIG. 3 is a diagram illustrating a mechanism of the detection, speculated in the embodiment.
- FIG. 4 is a diagram an example of an electrode array for carrying out the method of the embodiment.
- FIG. 5 is a diagram an example of an electrode array for carrying out the method of the embodiment.
- FIG. 6 is a diagram showing the experimental results in Example 1.
- FIG. 7 is a diagram showing the experimental results in Example 2.
- FIG. 8 is a diagram showing the experimental results in Example 2.
- FIG. 9 is a diagram showing the experimental results in Example 2.
- FIG. 10 is a diagram showing the experimental results in Example 3.
- FIG. 11 is a diagram showing the experimental results in Example 4.
- FIG. 12 is a diagram showing the experimental results in Example 5.
- the nucleic acid detection method is a method for detect a target nucleic acid in a sample.
- the target nucleic acid includes the first sequence.
- FIG. 1 shows a brief flow of the nucleic acid detection method according to the embodiment.
- the nucleic acid detection method comprises steps (A) to (D) set forth below.
- a reaction field is formed by placing a reaction mixture on an electrode, and the reaction mixture contains the sample, a primer set, a corresponding amplification enzyme, 4 mM to 30 mM in concentration of magnesium ion, and a redox probe.
- the primer set for amplifying the first sequence to obtain an amplification product, wherein the primer set contains at least a first primer complementary to a terminal of the first sequence and a second primer homologous to the other terminal of the first sequence.
- the redox probe has an oxidation reduction potential of ⁇ 0.5 V to 0.5 V, which generates a detectable electric signal of which amplitude increases with an increase in an amount of the amplification product existing in the reaction field.
- B The reaction field is maintained under an amplification reaction condition.
- C The electric signal from the redox probe is chronologically detected with the electrode while maintaining the reaction field under the amplification reaction condition.
- D Existence or quantity of the target nucleic acid is determined based on chronological variation in the amplitude of the electric signal, obtained in (C).
- reaction field is a region where an amplification reaction is carried out. The region is defined by the reaction mixture. In other words, a reaction field may be a region where a reaction mixture exists.
- the reaction mixture contains a sample, a primer-set, an amplification enzyme which corresponds thereto, a specific concentration of magnesium ion and a redox probe.
- the sample is a substance to be examined as to the presence/absence or quantity of a target nucleic acid.
- the sample may be an object to be analyzed, which may include a target nucleic acid.
- the sample may be, for example, in a liquid form.
- the sample may be bio-materials including blood, serum, leukocyte, urine, feces, sweat, saliva, oral mucosa, expectoration, lymph, spinal fluid, lacrimal fluid, mother milk, amniotic fluid, semen, tissue, biopsy and culture cells, environmental materials collected from the environment, artificial nucleic acids or the like, or mixtures of those. Further, a preparation formulated using any of above materials may as well be used as the sample.
- a pretreatment may be carried out on any of above materials to be used as a sample in the embodiment.
- the pretreatment may be any conventional means known by itself, such as a fragment, homogenization or extraction, for example.
- any of above materials may be collected from an organism or environment, and formulated into a condition suitable for the nucleic acid detection.
- a liquid containing a nucleic acid component which is obtained by extracting a nucleic acid from any of above materials by any means can be used as the sample.
- the target nucleic acid is a nucleic acid to be detected.
- the target nucleic acid includes a first sequence.
- the first sequence is a sequence which can be an index of the target nucleic acid, and may be selected from a full length of the sequence of the target nucleic acid.
- the first sequence may be a sequence specific to the target nucleic acid.
- the target nucleic acid is a single strand nucleic acid.
- the state of the target nucleic acid in the sample may be single-stranded.
- the state of the target nucleic acid in the sample may be a double strand formed from a target nucleic acid and a nucleic acid chain complementary to the target nucleic acid.
- the sample to be examined may contain both a single-stranded target nucleic acid and a double-stranded target nucleic acid.
- the length of the target sequence may be, for example, 50 to 500 bases, and preferably, 100 to 300 bases.
- the length of the first sequence may be, for example, 3 to 10 bases, 10 to 20 bases, 20 to 30 bases, 30 to 40 bases, 40 to 50 bases, 50 to 60 bases, 60 to 70 bases, 70 to 80 bases, 80 to 90 bases or 90 to 100 bases, and preferably, 10 to 50 bases.
- the amplification or amplification reaction means a process in which a target nucleic acid, or a complementary nucleic acid thereof, or an amplification product of each of these is continuously replicated using those as a template to produce an amplification product.
- the amplification method may be, for example, PCR, LAMP, RT-LAMP, SDA, NASBA, RCA, LCR, TMA, SmartAmp (registered trademark) or ICAN (registered trademark). Further, a reverse transcription reaction may be carried out together with the amplification reaction as needed, for example, simultaneously.
- the primer set is designed and/or selected to amplify the first sequence as the index using the target nucleic acid as a template so that an amplification product comprising the first sequence can be obtain, and the target nucleic acid can be detected.
- the primer set contains a first primer complementary to one terminal of the first sequence and a second primer homologous to the other terminal of the first sequence. With these primers, a range to be amplified on the target nucleic acid is specified.
- the target nucleic acid in a sample is a single-stranded DNA
- a complementary strand is formed by a primer set, and further the amplification reaction advances using it as a template.
- the target nucleic acid is RNA
- a reverse transcription reaction is carried out and the reverse transcription product is subjected to the amplification reaction.
- one primer set may contain one kind of forward primer as the first primer and one kind of reverse primer as the second primer.
- one primer set may contain an FIP primer as the first primer and a BIP primer as the second primer.
- the primer set for LAMP may further contain an F3 primer, B3 primer and LP gas primer, that is, LF primers and/or LB primers.
- the LAPM amplification product has a stem loop structure which includes a loop part which is a single-stranded region, and a stem part which is double-stranded region.
- the corresponding amplification enzyme is an amplification enzyme used for an amplification reaction.
- the amplification enzyme may be selected based on the kind of target nucleic acid, the amplification method, the primer set, and the presence/absence of a reverse transcription reaction, etc.
- the amplification enzyme may be DNA polymerase, RNA polymerase, or the like for example.
- the DNA-polymerase may be Bst, Bst2.0, Bst3.0, GspSSD, GspM, Tin, Bsm, Csa, 96-7, phi29, Omini-Amp (registered trademark), Aac, Bca BEST (registered trademark), Displace Ace (registered trademark), SD, Strand Displace (registered trademark), TOPOTAQ, Isotherm2G, Taq or a combination of any of these, for example.
- the kind of polymerase may be selected as needed. But Bst, GspSSD, or Tin is preferable since the sensitivity of detection can be increased therewith.
- the reaction liquid may further contain any type of reverse transcriptase in addition to amplification enzyme.
- Magnesium ion may be contained in the reaction mixture at a concentration of 4 mM to 30 mM to the reaction mixture.
- the inventors of the embodiments have found that in a reaction mixture containing the above-specified concentration of magnesium, the amplitude of the electric signal detected with the electrode increases with the increase in the amount of the amplification product present in a reaction field.
- Ahmed et al. (Analyst 138, 907-15 (2013)) report a detection carried out based on the decrease in the electric signal, caused by the increase in the amplification product, as an index.
- the decrease in an electric signal may occur not only by change in the amount of an amplification product present, but also by mixing of a reaction inhibiting material or the like.
- the increase in the electric signal, used as the index in this embodiment is not easily affected by a reaction inhibiting material or the like. Rather, the change in the amount of an amplification product is substantially directly reflected. Thus, higher-precision detection is achievable.
- magnesium pyrophosphate in which pyrophosphoric acid and magnesium ion are bonded together, is fully generated. As a result, magnesium pyrophosphate precipitates in the reaction mixture.
- the amount of the amplification product present in the reaction field is reflected as an increase in the amplitude of the electric signal from the redox probe.
- the concentration of magnesium ion contained in the reaction mixture should more preferably 4 to 12 mM, in which case magnesium pyrophosphate more easily precipitates. Even more preferable magnesium ion concentration is 5 to 10 mM.
- Magnesium ion can be contained in a reaction mixture by adding, for example, magnesium sulfide or magnesium chloride in the reaction mixture.
- a redox probe is a substance which has an oxidation reduction potential of ⁇ 0.5 V to 0.5 V and generates a detectable electric signal.
- the detectable electric signal may be, for example, an oxidation reduction potential or oxidation reduction current of the redox probe.
- An electric signal from the redox probe is detected with an electrode in contact with the reaction mixture. Further, the redox probe is electrostatically coupled with the amplification product in the reaction mixture.
- the redox probe may be a complex, for example.
- the complex may contain, for example, ruthenium (Ru), rhodium (Rh), platinum (Pt), cobalt (Co), chromium (Cr), cadmium (Cd), nickel (Ni), zinc (Zn), copper (Cu), osmium (Os), iron (Fe), or silver (Ag) as a central metal.
- the complex concerned may be, for example, amine complex, cyano complex, halogen complex, hydroxy complex, cyclopentadienyl complex, phenanthroline complex or bipyridine complex.
- the redox probe may be a pigment, for example.
- the pigment may be, for example, methylene blue, Nile blue or crystal violet.
- the redox probe is, for example, ruthenium hexaneamine (RuHex).
- RuHex ruthenium hexaneamine
- the redox probe should preferably be RuHex, since in which case the oxidation reduction potential is high and the sensitivity of the detection is enhanced.
- the concentration of the redox probe in the reaction mixture may be 0.1 ⁇ M to 100 mM, for example, preferably, 25 ⁇ M to 3 mM, and even more preferably 1 mM, in which case the sensitivity of the nucleic acid detection is enhanced.
- the redox probe is RuHex
- the reaction mixture may contain an ingredient required for the amplification reaction in addition to the above-listed ingredients.
- an additional ingredient may be, for example, salt, a substrate such as deoxynucleoside triphosphate (dNTP) required to form a new polynucleotide chain starting from a primer as the starting point, a thickener as a reaction reagent, a buffer for pH control, a surfactant, ion that increases the annealing specificity, ion used as a cofactor for the amplification enzyme and/or, when reverse transcription is carried out simultaneously, reverse transcriptase and a substrate required therefor.
- dNTP deoxynucleoside triphosphate
- the salt may be any conventionally known salt used to, for example, maintain suitable amplification environment in a nucleic acid amplification reaction.
- To maintain a suitable amplification environment in a nucleic acid amplification reaction may mean that, for example, the amplification enzyme maintains the tertiary structure so as to optimize the nucleic acid amplification activity.
- the salt may be potassium chloride, for example.
- the concentration of salt in the reaction mixture should desirably be, for example, 5 mol/L to 300 mol/L.
- the electrode is configured to detect electric signals. More specifically, a reaction field is formed on the electrode, and the surface of at least a part of the electrode is in contact with the reaction mixture. With this structure, an electric signal from the redox probe contained therein is detected.
- the electrode should preferably comprise a flat plane on a part of the surface thereof. When a reaction field is formed on this flat plane, the reaction field may be placed, for example, so as to cover the entire flat plane of the electrode, or to include the flat plane, or may be placed in a region partitioned by the flat plane.
- the electrode may be arranged inside the reaction container, for example, so as to be in contact with the bottom thereof or to be buried in the bottom, or may be disposed on a tabular substrate.
- FIG. 2 shows an example of the relationship between the reaction mixture and the electrode in the nucleic acid detection method according to the embodiment.
- the reaction field may be supported with a substrate, for example, which exposes the surface of the electrode from the surface of the substrate to be flush therewith.
- the reaction field may be formed on the electrode disposed on an upper surface of the substrate.
- the substrate 1 is in a solid phase.
- the substrate 1 may be, for example, resin, glass or silicon.
- the electrode 2 is disposed on the upper surface 1 a of the substrate 1 .
- the electrode 2 may be a metal film formed on the surface of the substrate 1 .
- the metal film may be, for example, gold.
- the metal film should desirably be gold because of its high sensitivity.
- the substrate 1 may comprise a reference pole and a counter pole in addition to the electrode 2 .
- the reaction field 10 may be formed from the reaction mixture 4 present on the electrode 2 .
- the ingredients to be contained in the reaction mixture described above should just be present in the reaction mixture at the time when it forms the reaction field. Therefore, these ingredients may be added to the reaction mixture, for example, before the reaction mixture is brought to the region which gives rise to the reaction field.
- some of the ingredients of the reaction mixture may be prepared separately, and thus some may be brought to the reaction mixture at the same time as that when the reaction mixture is brought to the region to become the reaction field, or before or after that time.
- some of the ingredients may be releasably immobilized to a solid phase or the like which is in contact with the reaction field, and brought into the reaction mixture by being released when the reaction mixture is brought thereto.
- the primer set when a primer set is releasably immobilized in advance, the primer set may be immobilized in, for example, a primer-immobilized region (not shown) which exists in the solid phase which is in contact with the reaction field 10 of the substrate 1 .
- the overall shape of the substrate 1 may be, for example, a container-like, a tabular, a globular, a rod-like, or a part of any of these.
- the size and form of the substrate 1 may be selected arbitrarily by the operator. Further, a substrate including a flow channel may be used as the substrate 1 .
- the substrate may comprise a plurality of electrodes arranged in an array as will be explained later.
- reaction field formed in the process (A) is maintained under an amplification reaction condition.
- the amplification reaction condition may be selected based on the amplification method selected, the type of the primer set, the kind of the target nucleic acid, the kind of the amplification enzyme, and/or the like.
- the amplification reaction condition may be an isothermal or temperature-varying amplification reaction condition.
- the isothermal amplification reaction condition is desirable.
- the isothermal amplification reaction condition should desirably be a LAMP amplification reaction condition.
- the reaction temperature may be selected depending on the kind of the amplification enzyme used for the nucleic acid detection method.
- the temperature may be, for example, 25° C. to 70° C., and preferably, 55° C. to 65° C.
- the amplification reaction is carried out and the amplification product can be produced.
- the electric signals can be detected by obtaining, for example, a current value, a potential value, a capacitance value or an impedance value with the electrode.
- the electric signals may be detected by measuring, for example, values of a plurality of kinds of electric signals such as a current value and a potential value.
- the detection may be performed by, for example, a device which can detect a current value, a potential value, a capacitance value or an impedance value.
- a device may be any of the well-known devices.
- the electric signals may be detected chronologically, which may be continuous or intermittently, that it, at a plurality of time points at a predetermined time interval.
- the continuous detection of an electric signal may be monitoring of the electric signal.
- a higher value of the electric signal is obtained as compared to the case where no amplification product nucleic acid exists by detecting from the start of the amplification reaction chronologically for a desired time. Or the rise of electric signal is observed at an earlier time. Or, before the electric signal increases with the increase in the amplification product, such a phenomenon is also observed that the peak of the oxidation reduction potential once shifts in a negative direction. Based on this, even a higher-precision measurement may be carried out by combining the shift of the peak potential in the negative direction, the amount of the electric signal and the peak shift measurement of the oxidation reduction potential.
- a process (D) the existence and/or quantity of a target nucleic acid are determined based on the chronologically change in the amplitude of the electric signal obtained in the process (C) above.
- the existence and/or the quantity of the target nucleic acid may be determined based on the result obtained by measuring the time required for the detection signal to exceed a predetermined threshold as a rise time.
- the existence and/or the quantity of the target nucleic acid may be determined by calculating the amount of the target nucleic acid in a sample with a method comprising the following processing steps: preparing several different standard sample nucleic acids whose amounts of nucleic acids existing are already known; measuring using the standard sample nucleic acids and preparing a calibration curve from the measurement result obtained for the amount of each nucleic acid; and comparing the measurement result of the target nucleic acid with the calibration curve prepared.
- nucleic acid detection method of the embodiment it is possible to detect and quantify a target nucleic acid in more simple way and at higher sensitivity than those of the conventional techniques. Moreover, according to the nucleic acid detection method of the embodiment, even many more kinds of target nucleic acids are detectable than with the conventional techniques.
- the amount of an amplification product existing can be reflected as an increase in electric signal in a simple way.
- FIG. 3( a ) shows an example of the substrate and the reaction field, used for the nucleic acid detection method of the embodiment.
- the substrate 1 is as described above.
- the reaction field 10 is formed from the reaction mixture 4 .
- redox probes 5 and magnesium ion 6 a are illustrated for convenience.
- magnesium ions 6 a bond to pyrophosphoric acid molecules 6 b to form magnesium pyrophosphate molecules 6 .
- the redox probes 5 may bond to the amplification products 7 to produce complexes 8 .
- the complexes 8 may bond to the magnesium pyrophosphate molecules 6 by electrostastically.
- the reaction mixture 4 having a concentration of magnesium ion 6 a of 4 mM or higher, magnesium pyrophosphate molecules 6 precipitate on the electrode. Therefore, the complexes 8 may precipitate on the bottom of the reaction field with the precipitation of the magnesium pyrophosphate molecules 6 ( FIG. 3 ( c ) ).
- the amount of the precipitate of the complexes 8 may increases.
- the redox probes 5 which approach or contact the electrode 2 increase. Therefore, the electric signal obtained with the electrode 2 increases.
- the electric signals from the redox probes 5 bonded to the amplification products 7 existing in the vicinity of the electrode 2 are directly detectable with the electrode.
- the amount of the amplification product 7 existing may be reflected as an increase in electric signal in a simple way.
- the nucleic acid detection method of the embodiment it is possible to achieve the detection precisely regardless of the sequence of the target nucleic acid to be detected. Moreover, according to such a detection method, a plurality of target nucleic acids can be detected with high precision in a simple way.
- a further embodiment provides a method of detecting a plurality of kinds of target nucleic acids, namely, the first to n-th target nucleic acids.
- the first to n-th target nucleic acids respectively contain the 1 1 -th to 1 n -th sequences, where n is an integer of 2 or greater.
- a substrate comprising a plurality of electrodes, i.e., an electrode array, may be used.
- the substrate shown in FIG. 4 comprises a plurality of electrodes 12 arranged on a surface 11 a in contact with a reaction field of the substrate 11 , and pads 9 electrically connected to electrodes 12 , respectively.
- the data as electric signals obtained with the electrodes 12 may be extracted from the pads 9 .
- the reaction mixtures each containing primer sets and samples, which correspond to the target nucleic acids to be measured are spotted respectively to the corresponding electrodes.
- the samples should be arranged on the respective electrodes so as not to be brought into contact with each other but only to the respective electrodes.
- a partition may be provided between electrodes, and further, for example, flow channels independent from each other may be provided to carry the reaction mixtures to the respective electrodes.
- the example provided above is directed to the case where a plurality of kinds of target nucleic acids are detected for one kind of sample, but it is also possible to similarly detect one kind of target nucleic acid or a plurality of kinds of target nucleic acids by an electrode array for a plurality of kinds of samples.
- a plurality of kinds of primer sets are used.
- the plurality of kinds of primer sets may contain primers for amplifying the 1 1 -th to 1 n -th sequences, respectively.
- a plurality of kinds of primer sets may be immobilized in advance to a plurality of primer-immobilized regions arranged on a surface in contact with the respective reaction field in an array to be independent from each other.
- a plurality of kinds of primer sets are immobilized onto or near the corresponding electrodes respectively on the electrode array, a plurality of kinds of target nucleic acids contained in one kind of sample can be simultaneously detected with a plurality of electrodes arranged so as to be in contact with the reaction mixture which forms the reaction field.
- the electrode array comprises a plurality of electrodes 22 so as to be in contact with one reaction field.
- a primer-immobilized region 30 is formed and a plurality of primer sets 31 corresponding to the primer-immobilized regions 30 are immobilized by each type.
- the positions of the electrodes and the primer sets are tied with each other, it becomes possible to obtain the data of the plurality of kinds of target nucleic acids and the detection results while being associated respectively with each other.
- the expression “arranged to be independent from each other” means that the amplification reactions carried out in the reaction fields by specific ones of the plurality of kinds of primer sets are located to be able to achieve the followings: the reactions are not influenced by those carried out by other kinds of primer sets; amplification products produced by the specific primer sets are not mixed with those produced by other kinds of primer sets; and the detection results of the specific amplification products to be detected by the corresponding electrodes can be identified with respect to those of the other amplification products. In order to achieve these, the intervals between the electrodes arranged on the electrode array can be adjusted.
- the interval between the electrodes may be 0.1 ⁇ m to 10 mm, and the interval between a corresponding electrode and an immobilized region of a respective primer set may be 0.1 ⁇ m to 10 mm.
- nucleic acid detection method which can simply detect nucleic acids with high sensitivity.
- an assay kit to detect a target nucleic acid in a sample.
- the target nucleic acid is as described above, and contains the first sequence.
- the assay kit contains the composition ingredients of the reaction mixture which forms a reaction field for an amplification reaction to take place.
- composition ingredients of the reaction mixture include a primer set, a specific quantity of magnesium ion, and a redox probe.
- the primer set contains at least a first primer complementary to a terminal of the first sequence and a second primer homologous to the other terminal of the first sequence.
- a primer set may be, for example, the above-described primer set.
- the magnesium ion may be contained in the assay kit in a specific quantity by which the final concentration thereof in the reaction mixture becomes 4 mM to 30 mM.
- the magnesium ion may be contained in the kit as magnesium sulfide or magnesium chloride, for example.
- the redox probe has an oxidation reduction potential of ⁇ 0.5 V to 0.5 V and generates a detectable electric signal.
- the amplitude of the electric signal increases with the increase in the amount of the amplification product existing in a reaction field.
- the redox probe may be, for example, the one described above.
- the assay kit may further contain a reaction reagent.
- the reaction reagent may be a reagent required for the amplification reaction.
- the reaction reagent may contain, for example, the above-mentioned corresponding amplification enzyme, a substrate such as deoxynucleoside triphosphate required when forming a new polynucleotide chain with starting from the primer as the starting point, or when reverse transcription to be carried out simultaneously, an enzyme such as reverse transcriptase and a substrate required therefor, and further a buffer for maintaining suitable amplification environment, such as a salt.
- a thickener may be contained as a reaction reagent.
- composition ingredients of the reaction mixture may be individually contained in the assay kit, or some or all of them may be mixedly contained in the assay kit.
- nucleic acids can be detected simply with high sensitivity.
- the assay kit contains a substrate.
- the substrate is for supporting a reaction field for the amplification reaction to take place, formed by the existence of the above-described reaction mixture.
- the substrate comprises, on a surface thereof, an electrode for detecting an electric signal from a redox probe.
- the electrode is disposed so as to form the reaction field on itself.
- Such a substrate may be, for example, the one shown in FIG. 2 .
- composition ingredients of the reaction mixture may be releasably immobilized to the surface to be brought into contact with a reaction field of the substrate so as to be brought into the reaction field.
- a reaction field may be formed from a reaction mixture containing the composition ingredients, existing on an electrode of the substrate. With use of the reaction field, it is possible to detect nucleic acid simply with high sensitivity.
- an assay kit which can detect nucleic acid simply with high sensitivity.
- a reaction mixture was prepared, which contains an artificial sequence of parvo virus (10 5 copies, 1 ⁇ L) (listed in Table 1 as SEQ ID NO: 1) as an amplification product, an F3 primer (SEQ ID NO: 2), a B3 primer (SEQ ID NO: 3), an FIP primer (SEQ ID NO: 4), a BIP primer (SEQ ID NO: 5), an Lb primer (SEQ ID NO: 6) as a LAMP primer shown in Table 2, RuHex (25 microM) as a redox probe, KCl (60 mM), magnesium ion (8 mM), ammonium ion (10 mM), betaine (0.8 M), dNTPs (1.4 mM each) and polymerase (GspSSD) (8 units).
- an artificial sequence of parvo virus (10 5 copies, 1 ⁇ L) (listed in Table 1 as SEQ ID NO: 1) as an amplification product
- an F3 primer SEQ ID NO: 2
- a B3 primer SEQ ID NO: 3
- a sample was further prepared in which the artificial sequence of parvo virus was not added to the reaction mixture.
- the reaction mixture was brought onto the surface of the substrate having the electrode, and they were warmed isothermally at 67° C., to start the amplification reaction.
- the electric signal was measured by a square wave voltammetry (SWV) method.
- FIG. 6( a ) is a graph showing the chronological variation in the reduction peak current in each of the case where there was zero copy of artificial sequence (SEQ ID NO: 1) of parvo virus and the case of 10 5 copies. In the case of 10 5 copies, the reduction peak current remarkably increased.
- FIG. 6( b ) is a graph showing the chronological variation in the reduction peak potential in each of the case where there was zero copy of artificial sequence of parvo virus and the case of 10 5 copies. In the case of 10 5 copies, the reduction peak potential shifted.
- reaction mixtures similar to that of Example 1 which respectively contain zero copy, 10 2 copies, 10 3 copies, 10 4 copies and 10 5 copies of the artificial sequence (SEQ ID NO: 1) of parvo virus.
- these reaction mixtures were warmed isothermally at 67° C., to start the amplification reactions. As the amplification reactions proceeded, the electric signals were measured by the SWV method.
- FIGS. 7 and 8 are each a graph showing the chronological variation in the reduction peak potential in the reaction mixture containing the respective number of copies of the artificial sequence of parvo virus.
- FIGS. 8( f ) to 8( i ) are each a graphs showing the difference in amount of chronological variation in terms of the reduction peak potential between FIG. 7( a ) and each of FIGS. 7( b ) to 7( e ) .
- an arrow indicates the time (potential rise time) when the variation amount of the peak reduction potential shifted by 1 mV/min or more. As the number of copies of parvo virus artificial sequence was greater, the potential rise time was shorter.
- FIG. 7( a ) to 7( e ) are each a graph showing the chronological variation in the reduction peak potential in the reaction mixture containing the respective number of copies of the artificial sequence of parvo virus.
- FIGS. 8( f ) to 8( i ) are each a graphs showing the difference in amount of chronological variation in terms of the reduction peak
- a reaction mixture having the same conditions as those of Example 1 except that it contained 1 mM of RuHex and another reaction mixture having the same conditions as that of Example 1 were prepared.
- each of the reaction mixtures was warmed isothermally at 67° C., to start the amplification reaction.
- the electric signals were measured by a linear sweep voltammetry (LSV) method (sweep rate: 0.1 V/s). The results are shown in FIG. 10 .
- the variation amount of the reduction peak current was greater than that of the condition where RuHex was 25 ⁇ M ( FIG. 6( a ) ).
- the concentration of the redox probe in the reaction mixture was 1 mM, the detection sensitivity was improved as compared to the case of 25 ⁇ M. If the concentration of RuHex was 3 mM or more, the amplification reaction was inhibited; therefore a preferable range is 25 ⁇ M to 3 mM.
- reaction mixtures similar to that of Example 1 were prepared, which respectively contain zero copy, 10 2 copies, 10 3 copies, 10 4 copies and 10 5 copies of the artificial sequence (SEQ ID NO: 1) of parvo virus. These reaction mixtures were brought onto the surface of the substrate having electrodes, and they were warmed isothermally at 67° C., to start the amplification reactions. As the amplification reactions proceeded, the electric signals were measured by the LSV method (sweep rate: 0.5 V/s).
- FIG. 11 The results are shown in FIG. 11 .
- FIG. 11( a ) is a graph showing the chronological variation in current value. As the number of copies of the artificial sequence of parvo virus was greater, the current rise time was shorter.
- FIG. 11( b ) is a graph which plotted the current rise time in each case of the respective numbers of copies of parvo virus artificial sequence, together with a calibration curve. The R 2 value of the calibration curve was 0.9071. From these results, it was demonstrated that there is a correlation between the quantity of parvo virus artificial sequence existing and the current rise time. Thus, it was suggested that with use of a substrate comprising electrodes arranged in an array, the quantity of amplification product in early stages of an amplification reaction can be determined (quantification) based on the potential rise time.
- reaction mixtures were prepared from the same ingredients as those of Example 1 except that they respectively contain 2.0 mM, 3.5 mM, 4 mM and 4.5 mM of magnesium ion, and 10 3 copies of the parvo virus artificial sequence (SEQ ID NO: 1) and RuHex (1 mM).
- SEQ ID NO: 1 the parvo virus artificial sequence
- RuHex the parvo virus artificial sequence
- Each of the reaction mixtures was brought onto the surface of a substrate such as of Example 1 having the electrode without application of mercaptohexanol, and was warmed isothermally at 65° C., to start the amplification reaction.
- the electric signals were measured by the LSV method (sweep rate: 0.5 V/s).
- FIG. 12 is a graph showing the chronological variation in relative value of the peak current value with respect to the peak current value before the starting of the amplification reaction start being set to a value of 1.
- the current value decreased as the amplification reaction advanced.
- the reaction mixture having a magnesium ion concentration of 4 mM or higher the current value decreased once, and then increased.
- the current rise time was shorter than the case of 4 mM, and the obtained current value itself was high.
- the reaction mixtures were prepared from the same ingredients as those of Example 1 except that they respectively contain 2.0 mM to 12 mM of magnesium ion, and 10 3 copies of the parvo virus artificial sequence (SEQ ID NO: 1). 20 ⁇ L of each of the reaction mixtures was dispensed into a respective 0.2-mL tube, and warmed isothermally at 65° C., to start the amplification reaction. After 60 minutes of the amplification reaction in each mixture, the existence of the amplification product was examined by electrophoresis.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
- This application is based upon and claims the benefit of priority from Japanese Patent Application No. 2016-216159, filed Nov. 4, 2016, the entire contents of which are incorporated herein by reference.
- Embodiments described herein relate generally to a nucleic acid detection method and an assay kit.
- At present, with progress of genetic-testing technology, the nucleic acid testing is carried out in various scenes, such as clinical diagnosis and criminal investigations. The target genes are detected or quantified by methods such as the real-time PCR method or microarray method. For example, the real-time PCR method is accompanied by the amplification of nucleic acid, and therefore its sensitivity is high and the quantitative range is wide. On the other hand, with the microarray method, it is possible to detect tens of thousands or more kinds of target genes simultaneously. Further, a detection method which combines these methods has been proposed.
- Under such circumstances, there is a demand for further development of a detection method which can detect nucleic acid simply at high sensitivity.
-
FIG. 1 is a flowchart showing an example of a nucleic acid detection method in an embodiment. -
FIG. 2 is a diagram showing an example of a substrate of the embodiment. -
FIG. 3 is a diagram illustrating a mechanism of the detection, speculated in the embodiment. -
FIG. 4 is a diagram an example of an electrode array for carrying out the method of the embodiment. -
FIG. 5 is a diagram an example of an electrode array for carrying out the method of the embodiment. -
FIG. 6 is a diagram showing the experimental results in Example 1. -
FIG. 7 is a diagram showing the experimental results in Example 2. -
FIG. 8 is a diagram showing the experimental results in Example 2. -
FIG. 9 is a diagram showing the experimental results in Example 2. -
FIG. 10 is a diagram showing the experimental results in Example 3. -
FIG. 11 is a diagram showing the experimental results in Example 4. -
FIG. 12 is a diagram showing the experimental results in Example 5. - Various embodiments will be described below with reference to the accompanying drawings. Further, the drawings are schematic diagrams designed to assist the reader to understand the embodiments easily. Thus, there may be sections where the shape, dimensions, ratio, etc., are different from those of the actual devices, but they can be re-designed as needed with reference to the following explanations and publicly known techniques.
- In general, according to one embodiment, the nucleic acid detection method is a method for detect a target nucleic acid in a sample. The target nucleic acid includes the first sequence.
FIG. 1 shows a brief flow of the nucleic acid detection method according to the embodiment. - The nucleic acid detection method comprises steps (A) to (D) set forth below. (A) A reaction field is formed by placing a reaction mixture on an electrode, and the reaction mixture contains the sample, a primer set, a corresponding amplification enzyme, 4 mM to 30 mM in concentration of magnesium ion, and a redox probe. The primer set for amplifying the first sequence to obtain an amplification product, wherein the primer set contains at least a first primer complementary to a terminal of the first sequence and a second primer homologous to the other terminal of the first sequence. The redox probe has an oxidation reduction potential of −0.5 V to 0.5 V, which generates a detectable electric signal of which amplitude increases with an increase in an amount of the amplification product existing in the reaction field. (B) The reaction field is maintained under an amplification reaction condition. (C) The electric signal from the redox probe is chronologically detected with the electrode while maintaining the reaction field under the amplification reaction condition. (D) Existence or quantity of the target nucleic acid is determined based on chronological variation in the amplitude of the electric signal, obtained in (C).
- In step (A), a reaction mixture is placed on an electrode, thus forming a reaction field. A “reaction field” is a region where an amplification reaction is carried out. The region is defined by the reaction mixture. In other words, a reaction field may be a region where a reaction mixture exists.
- The reaction mixture contains a sample, a primer-set, an amplification enzyme which corresponds thereto, a specific concentration of magnesium ion and a redox probe.
- The sample is a substance to be examined as to the presence/absence or quantity of a target nucleic acid. In other words, the sample may be an object to be analyzed, which may include a target nucleic acid. The sample may be, for example, in a liquid form. For example, the sample may be bio-materials including blood, serum, leukocyte, urine, feces, sweat, saliva, oral mucosa, expectoration, lymph, spinal fluid, lacrimal fluid, mother milk, amniotic fluid, semen, tissue, biopsy and culture cells, environmental materials collected from the environment, artificial nucleic acids or the like, or mixtures of those. Further, a preparation formulated using any of above materials may as well be used as the sample. For example, a pretreatment may be carried out on any of above materials to be used as a sample in the embodiment. The pretreatment may be any conventional means known by itself, such as a fragment, homogenization or extraction, for example. For example, any of above materials may be collected from an organism or environment, and formulated into a condition suitable for the nucleic acid detection. For example, a liquid containing a nucleic acid component which is obtained by extracting a nucleic acid from any of above materials by any means can be used as the sample.
- The target nucleic acid is a nucleic acid to be detected. The target nucleic acid includes a first sequence. The first sequence is a sequence which can be an index of the target nucleic acid, and may be selected from a full length of the sequence of the target nucleic acid. For example, the first sequence may be a sequence specific to the target nucleic acid. The target nucleic acid is a single strand nucleic acid. The state of the target nucleic acid in the sample may be single-stranded. Or, the state of the target nucleic acid in the sample may be a double strand formed from a target nucleic acid and a nucleic acid chain complementary to the target nucleic acid. For example, the sample to be examined may contain both a single-stranded target nucleic acid and a double-stranded target nucleic acid. The length of the target sequence may be, for example, 50 to 500 bases, and preferably, 100 to 300 bases.
- The length of the first sequence may be, for example, 3 to 10 bases, 10 to 20 bases, 20 to 30 bases, 30 to 40 bases, 40 to 50 bases, 50 to 60 bases, 60 to 70 bases, 70 to 80 bases, 80 to 90 bases or 90 to 100 bases, and preferably, 10 to 50 bases.
- The amplification or amplification reaction means a process in which a target nucleic acid, or a complementary nucleic acid thereof, or an amplification product of each of these is continuously replicated using those as a template to produce an amplification product.
- The amplification method may be, for example, PCR, LAMP, RT-LAMP, SDA, NASBA, RCA, LCR, TMA, SmartAmp (registered trademark) or ICAN (registered trademark). Further, a reverse transcription reaction may be carried out together with the amplification reaction as needed, for example, simultaneously.
- The primer set is designed and/or selected to amplify the first sequence as the index using the target nucleic acid as a template so that an amplification product comprising the first sequence can be obtain, and the target nucleic acid can be detected. The primer set contains a first primer complementary to one terminal of the first sequence and a second primer homologous to the other terminal of the first sequence. With these primers, a range to be amplified on the target nucleic acid is specified.
- For example, when the target nucleic acid in a sample is a single-stranded DNA, a complementary strand is formed by a primer set, and further the amplification reaction advances using it as a template. Moreover, when the target nucleic acid is RNA, a reverse transcription reaction is carried out and the reverse transcription product is subjected to the amplification reaction.
- For example, in the case of a primer set for PCR, one primer set may contain one kind of forward primer as the first primer and one kind of reverse primer as the second primer.
- Moreover, for example, in the case of a primer set for LAMP, one primer set may contain an FIP primer as the first primer and a BIP primer as the second primer. The primer set for LAMP may further contain an F3 primer, B3 primer and LP gas primer, that is, LF primers and/or LB primers. The LAPM amplification product has a stem loop structure which includes a loop part which is a single-stranded region, and a stem part which is double-stranded region.
- The corresponding amplification enzyme is an amplification enzyme used for an amplification reaction. The amplification enzyme may be selected based on the kind of target nucleic acid, the amplification method, the primer set, and the presence/absence of a reverse transcription reaction, etc. The amplification enzyme may be DNA polymerase, RNA polymerase, or the like for example.
- The DNA-polymerase may be Bst, Bst2.0, Bst3.0, GspSSD, GspM, Tin, Bsm, Csa, 96-7, phi29, Omini-Amp (registered trademark), Aac, Bca BEST (registered trademark), Displace Ace (registered trademark), SD, Strand Displace (registered trademark), TOPOTAQ, Isotherm2G, Taq or a combination of any of these, for example. The kind of polymerase may be selected as needed. But Bst, GspSSD, or Tin is preferable since the sensitivity of detection can be increased therewith. The reaction liquid may further contain any type of reverse transcriptase in addition to amplification enzyme.
- Magnesium ion may be contained in the reaction mixture at a concentration of 4 mM to 30 mM to the reaction mixture.
- The inventors of the embodiments have found that in a reaction mixture containing the above-specified concentration of magnesium, the amplitude of the electric signal detected with the electrode increases with the increase in the amount of the amplification product present in a reaction field.
- Conversely, Ahmed et al. (Analyst 138, 907-15 (2013)) report a detection carried out based on the decrease in the electric signal, caused by the increase in the amplification product, as an index. Note, however, that the decrease in an electric signal may occur not only by change in the amount of an amplification product present, but also by mixing of a reaction inhibiting material or the like. On the other hand, the increase in the electric signal, used as the index in this embodiment, is not easily affected by a reaction inhibiting material or the like. Rather, the change in the amount of an amplification product is substantially directly reflected. Thus, higher-precision detection is achievable.
- In the reaction mixture with a concentration of magnesium ion being 4 mM or higher, the amplification reaction is promoted. Further, with the generation of the amplification product, magnesium pyrophosphate, in which pyrophosphoric acid and magnesium ion are bonded together, is fully generated. As a result, magnesium pyrophosphate precipitates in the reaction mixture. Although a detailed explanation will be provided later, due to the generation of the precipitate, the amount of the amplification product present in the reaction field is reflected as an increase in the amplitude of the electric signal from the redox probe.
- The concentration of magnesium ion contained in the reaction mixture should more preferably 4 to 12 mM, in which case magnesium pyrophosphate more easily precipitates. Even more preferable magnesium ion concentration is 5 to 10 mM.
- Magnesium ion can be contained in a reaction mixture by adding, for example, magnesium sulfide or magnesium chloride in the reaction mixture.
- With a concentration of magnesium ion of 4 mM to 30 mM in the reaction mixture, the amplification reaction is promoted, thereby making it possible to amplify various types of sequences of a wide range efficiently, for example, without depending on the sequence. Thus, various types of sequences can be detected efficiently, for example.
- A redox probe is a substance which has an oxidation reduction potential of −0.5 V to 0.5 V and generates a detectable electric signal. The detectable electric signal may be, for example, an oxidation reduction potential or oxidation reduction current of the redox probe. An electric signal from the redox probe is detected with an electrode in contact with the reaction mixture. Further, the redox probe is electrostatically coupled with the amplification product in the reaction mixture.
- The redox probe may be a complex, for example. The complex may contain, for example, ruthenium (Ru), rhodium (Rh), platinum (Pt), cobalt (Co), chromium (Cr), cadmium (Cd), nickel (Ni), zinc (Zn), copper (Cu), osmium (Os), iron (Fe), or silver (Ag) as a central metal. The complex concerned may be, for example, amine complex, cyano complex, halogen complex, hydroxy complex, cyclopentadienyl complex, phenanthroline complex or bipyridine complex.
- The redox probe may be a pigment, for example. The pigment may be, for example, methylene blue, Nile blue or crystal violet.
- The redox probe is, for example, ruthenium hexaneamine (RuHex). In this case, with application of voltage to the electrode, RuHex3+ is reduced to RuHex2+ and electrons are released. As these electrons flow into the electrode, the oxidation reduction potential or current of RuHex is detected with the electrode. The redox probe should preferably be RuHex, since in which case the oxidation reduction potential is high and the sensitivity of the detection is enhanced.
- The concentration of the redox probe in the reaction mixture may be 0.1 μM to 100 mM, for example, preferably, 25 μM to 3 mM, and even more preferably 1 mM, in which case the sensitivity of the nucleic acid detection is enhanced. In particular, when the redox probe is RuHex, it is desirable that the redox probe be contained in a range of 25 μM to 3 mM. If the amount of the redox probe in the reaction mixture is excessively low, the binding to the amplification product may be insufficient, which may cause the deterioration of the detection sensitivity. On the other hand, when it is excessive, the amplification reaction may be inhibited.
- The reaction mixture may contain an ingredient required for the amplification reaction in addition to the above-listed ingredients. Such an additional ingredient may be, for example, salt, a substrate such as deoxynucleoside triphosphate (dNTP) required to form a new polynucleotide chain starting from a primer as the starting point, a thickener as a reaction reagent, a buffer for pH control, a surfactant, ion that increases the annealing specificity, ion used as a cofactor for the amplification enzyme and/or, when reverse transcription is carried out simultaneously, reverse transcriptase and a substrate required therefor.
- The salt may be any conventionally known salt used to, for example, maintain suitable amplification environment in a nucleic acid amplification reaction. To maintain a suitable amplification environment in a nucleic acid amplification reaction may mean that, for example, the amplification enzyme maintains the tertiary structure so as to optimize the nucleic acid amplification activity. The salt may be potassium chloride, for example. The concentration of salt in the reaction mixture should desirably be, for example, 5 mol/L to 300 mol/L.
- The electrode is configured to detect electric signals. More specifically, a reaction field is formed on the electrode, and the surface of at least a part of the electrode is in contact with the reaction mixture. With this structure, an electric signal from the redox probe contained therein is detected. The electrode should preferably comprise a flat plane on a part of the surface thereof. When a reaction field is formed on this flat plane, the reaction field may be placed, for example, so as to cover the entire flat plane of the electrode, or to include the flat plane, or may be placed in a region partitioned by the flat plane.
- For example, the electrode may be arranged inside the reaction container, for example, so as to be in contact with the bottom thereof or to be buried in the bottom, or may be disposed on a tabular substrate.
-
FIG. 2 shows an example of the relationship between the reaction mixture and the electrode in the nucleic acid detection method according to the embodiment. - The reaction field may be supported with a substrate, for example, which exposes the surface of the electrode from the surface of the substrate to be flush therewith. In that case, the reaction field may be formed on the electrode disposed on an upper surface of the substrate. The
substrate 1 is in a solid phase. Thesubstrate 1 may be, for example, resin, glass or silicon. Theelectrode 2 is disposed on theupper surface 1 a of thesubstrate 1. Theelectrode 2 may be a metal film formed on the surface of thesubstrate 1. The metal film may be, for example, gold. The metal film should desirably be gold because of its high sensitivity. Thesubstrate 1 may comprise a reference pole and a counter pole in addition to theelectrode 2. - With the reaction mixture 4 brought on the
electrode 2 described above, thereaction field 10 may be formed from the reaction mixture 4 present on theelectrode 2. - The ingredients to be contained in the reaction mixture described above should just be present in the reaction mixture at the time when it forms the reaction field. Therefore, these ingredients may be added to the reaction mixture, for example, before the reaction mixture is brought to the region which gives rise to the reaction field. Alternatively, some of the ingredients of the reaction mixture may be prepared separately, and thus some may be brought to the reaction mixture at the same time as that when the reaction mixture is brought to the region to become the reaction field, or before or after that time. Or before the reaction mixture is brought to the region to become the reaction field, some of the ingredients may be releasably immobilized to a solid phase or the like which is in contact with the reaction field, and brought into the reaction mixture by being released when the reaction mixture is brought thereto.
- For example, when a primer set is releasably immobilized in advance, the primer set may be immobilized in, for example, a primer-immobilized region (not shown) which exists in the solid phase which is in contact with the
reaction field 10 of thesubstrate 1. - In a further embodiment, the overall shape of the
substrate 1 may be, for example, a container-like, a tabular, a globular, a rod-like, or a part of any of these. The size and form of thesubstrate 1 may be selected arbitrarily by the operator. Further, a substrate including a flow channel may be used as thesubstrate 1. - In a further embodiment, the substrate may comprise a plurality of electrodes arranged in an array as will be explained later.
- In a process (B), the reaction field formed in the process (A) is maintained under an amplification reaction condition.
- The amplification reaction condition may be selected based on the amplification method selected, the type of the primer set, the kind of the target nucleic acid, the kind of the amplification enzyme, and/or the like. For example, the amplification reaction condition may be an isothermal or temperature-varying amplification reaction condition. Here, the isothermal amplification reaction condition is desirable. The isothermal amplification reaction condition should desirably be a LAMP amplification reaction condition. When adopting the isothermal amplification reaction condition, the reaction temperature may be selected depending on the kind of the amplification enzyme used for the nucleic acid detection method. The temperature may be, for example, 25° C. to 70° C., and preferably, 55° C. to 65° C.
- By maintaining the reaction field under the reaction condition, the amplification reaction is carried out and the amplification product can be produced.
- In a process (C), while maintaining the field under the amplification reaction condition, electric signals from the redox probe are detected chronologically with the electrode.
- The electric signals can be detected by obtaining, for example, a current value, a potential value, a capacitance value or an impedance value with the electrode. The electric signals may be detected by measuring, for example, values of a plurality of kinds of electric signals such as a current value and a potential value. The detection may be performed by, for example, a device which can detect a current value, a potential value, a capacitance value or an impedance value. Such a device may be any of the well-known devices.
- The electric signals may be detected chronologically, which may be continuous or intermittently, that it, at a plurality of time points at a predetermined time interval. For example, the continuous detection of an electric signal may be monitoring of the electric signal. When an amplification product nucleic acid exists, a higher value of the electric signal is obtained as compared to the case where no amplification product nucleic acid exists by detecting from the start of the amplification reaction chronologically for a desired time. Or the rise of electric signal is observed at an earlier time. Or, before the electric signal increases with the increase in the amplification product, such a phenomenon is also observed that the peak of the oxidation reduction potential once shifts in a negative direction. Based on this, even a higher-precision measurement may be carried out by combining the shift of the peak potential in the negative direction, the amount of the electric signal and the peak shift measurement of the oxidation reduction potential.
- In a process (D), the existence and/or quantity of a target nucleic acid are determined based on the chronologically change in the amplitude of the electric signal obtained in the process (C) above.
- The existence and/or the quantity of the target nucleic acid may be determined based on the result obtained by measuring the time required for the detection signal to exceed a predetermined threshold as a rise time. Alternatively, the existence and/or the quantity of the target nucleic acid may be determined by calculating the amount of the target nucleic acid in a sample with a method comprising the following processing steps: preparing several different standard sample nucleic acids whose amounts of nucleic acids existing are already known; measuring using the standard sample nucleic acids and preparing a calibration curve from the measurement result obtained for the amount of each nucleic acid; and comparing the measurement result of the target nucleic acid with the calibration curve prepared.
- According to the nucleic acid detection method of the embodiment, it is possible to detect and quantify a target nucleic acid in more simple way and at higher sensitivity than those of the conventional techniques. Moreover, according to the nucleic acid detection method of the embodiment, even many more kinds of target nucleic acids are detectable than with the conventional techniques.
- With the embodiment described above, the amount of an amplification product existing can be reflected as an increase in electric signal in a simple way. As a result, it becomes possible to detect or quantify a target nucleic acid in a sample with high precision in a simple way.
- One reason why the amount of an amplification product existing can be detected as an increase in electric signal in the embodiment described above can be considered as follows. The following explanation will be provided with reference to
FIG. 3 . -
FIG. 3(a) shows an example of the substrate and the reaction field, used for the nucleic acid detection method of the embodiment. Thesubstrate 1 is as described above. Thereaction field 10 is formed from the reaction mixture 4. Here, of the ingredients contained in the reaction mixture 4, redox probes 5 andmagnesium ion 6 a are illustrated for convenience. Whenamplification products 7 andpyrophosphoric acid molecules 6 b are produced by the amplification reaction (FIG. 3 (b) ),magnesium ions 6 a bond topyrophosphoric acid molecules 6 b to formmagnesium pyrophosphate molecules 6. Further, the redox probes 5 may bond to theamplification products 7 to producecomplexes 8. Thecomplexes 8 may bond to themagnesium pyrophosphate molecules 6 by electrostastically. In the reaction mixture 4 having a concentration ofmagnesium ion 6 a of 4 mM or higher,magnesium pyrophosphate molecules 6 precipitate on the electrode. Therefore, thecomplexes 8 may precipitate on the bottom of the reaction field with the precipitation of the magnesium pyrophosphate molecules 6 (FIG. 3 (c) ). As theamplification products 7 and/ormagnesium pyrophosphate molecules 6 increase, the amount of the precipitate of thecomplexes 8 may increases. As the amount of precipitate of thecomplexes 8 increases, the redox probes 5 which approach or contact theelectrode 2 increase. Therefore, the electric signal obtained with theelectrode 2 increases. With the above-described mechanism, the electric signals from the redox probes 5 bonded to theamplification products 7 existing in the vicinity of theelectrode 2 are directly detectable with the electrode. As a result, the amount of theamplification product 7 existing may be reflected as an increase in electric signal in a simple way. - With use of such a detection principle, according to the nucleic acid detection method of the embodiment, it is possible to achieve the detection precisely regardless of the sequence of the target nucleic acid to be detected. Moreover, according to such a detection method, a plurality of target nucleic acids can be detected with high precision in a simple way.
- A further embodiment provides a method of detecting a plurality of kinds of target nucleic acids, namely, the first to n-th target nucleic acids.
- The first to n-th target nucleic acids respectively contain the 11-th to 1n-th sequences, where n is an integer of 2 or greater.
- In order to detect a plurality of kinds of target nucleic acids such as above, a substrate comprising a plurality of electrodes, i.e., an electrode array, may be used. The substrate shown in
FIG. 4 comprises a plurality ofelectrodes 12 arranged on asurface 11 a in contact with a reaction field of thesubstrate 11, andpads 9 electrically connected toelectrodes 12, respectively. The data as electric signals obtained with theelectrodes 12 may be extracted from thepads 9. - In order to detect a plurality of kinds of target nucleic acids for one kind of sample, it suffices if, for example, the reaction mixtures each containing primer sets and samples, which correspond to the target nucleic acids to be measured, are spotted respectively to the corresponding electrodes. In this case, the samples should be arranged on the respective electrodes so as not to be brought into contact with each other but only to the respective electrodes. Here, a partition may be provided between electrodes, and further, for example, flow channels independent from each other may be provided to carry the reaction mixtures to the respective electrodes. The example provided above is directed to the case where a plurality of kinds of target nucleic acids are detected for one kind of sample, but it is also possible to similarly detect one kind of target nucleic acid or a plurality of kinds of target nucleic acids by an electrode array for a plurality of kinds of samples. When detecting a plurality of kinds of target nucleic acids, a plurality of kinds of primer sets are used. The plurality of kinds of primer sets may contain primers for amplifying the 11-th to 1n-th sequences, respectively.
- Moreover, a plurality of kinds of primer sets may be immobilized in advance to a plurality of primer-immobilized regions arranged on a surface in contact with the respective reaction field in an array to be independent from each other.
- When a plurality of kinds of primer sets are immobilized onto or near the corresponding electrodes respectively on the electrode array, a plurality of kinds of target nucleic acids contained in one kind of sample can be simultaneously detected with a plurality of electrodes arranged so as to be in contact with the reaction mixture which forms the reaction field.
- The positions of primer-immobilized regions such as above are shown in
FIG. 5 . For example, as shown inFIG. 5 , the electrode array comprises a plurality ofelectrodes 22 so as to be in contact with one reaction field. In the vicinity of and/or on each of theelectrodes 22, a primer-immobilizedregion 30 is formed and a plurality of primer sets 31 corresponding to the primer-immobilizedregions 30 are immobilized by each type. For example, when the positions of the electrodes and the primer sets are tied with each other, it becomes possible to obtain the data of the plurality of kinds of target nucleic acids and the detection results while being associated respectively with each other. - The expression “arranged to be independent from each other” means that the amplification reactions carried out in the reaction fields by specific ones of the plurality of kinds of primer sets are located to be able to achieve the followings: the reactions are not influenced by those carried out by other kinds of primer sets; amplification products produced by the specific primer sets are not mixed with those produced by other kinds of primer sets; and the detection results of the specific amplification products to be detected by the corresponding electrodes can be identified with respect to those of the other amplification products. In order to achieve these, the intervals between the electrodes arranged on the electrode array can be adjusted.
- For example, the interval between the electrodes may be 0.1 μm to 10 mm, and the interval between a corresponding electrode and an immobilized region of a respective primer set may be 0.1 μm to 10 mm.
- With such structure, it is possible to simultaneously detect a plurality of kinds of target nucleic acids existing in one reaction field.
- According to the embodiment described above, it becomes possible to detect a plurality of kinds of sequences efficiently with high sensitivity regardless of the kind of sequence. Moreover, by using the reaction mixture of the composition according to the embodiment, more kinds of sequences can be amplified, for example, efficiently. Therefore, it is possible to detect more kinds of target nucleic acids efficiently with high precision, thereby improving the efficiency of examination.
- According to the embodiment described above, there is provided a nucleic acid detection method which can simply detect nucleic acids with high sensitivity.
- According to the further embodiment, there is provided an assay kit to detect a target nucleic acid in a sample. The target nucleic acid is as described above, and contains the first sequence. The assay kit contains the composition ingredients of the reaction mixture which forms a reaction field for an amplification reaction to take place.
- The composition ingredients of the reaction mixture include a primer set, a specific quantity of magnesium ion, and a redox probe.
- The primer set contains at least a first primer complementary to a terminal of the first sequence and a second primer homologous to the other terminal of the first sequence. Such a primer set may be, for example, the above-described primer set.
- The magnesium ion may be contained in the assay kit in a specific quantity by which the final concentration thereof in the reaction mixture becomes 4 mM to 30 mM. The magnesium ion may be contained in the kit as magnesium sulfide or magnesium chloride, for example.
- The redox probe has an oxidation reduction potential of −0.5 V to 0.5 V and generates a detectable electric signal. The amplitude of the electric signal increases with the increase in the amount of the amplification product existing in a reaction field. The redox probe may be, for example, the one described above.
- The assay kit may further contain a reaction reagent. The reaction reagent may be a reagent required for the amplification reaction. The reaction reagent may contain, for example, the above-mentioned corresponding amplification enzyme, a substrate such as deoxynucleoside triphosphate required when forming a new polynucleotide chain with starting from the primer as the starting point, or when reverse transcription to be carried out simultaneously, an enzyme such as reverse transcriptase and a substrate required therefor, and further a buffer for maintaining suitable amplification environment, such as a salt. Further, a thickener may be contained as a reaction reagent.
- Each of these composition ingredients of the reaction mixture may be individually contained in the assay kit, or some or all of them may be mixedly contained in the assay kit.
- With use of the assay kit containing these ingredients, and for example, the adoption of the above-described nucleic acid detection method, nucleic acids can be detected simply with high sensitivity.
- In the further embodiment, the assay kit contains a substrate.
- The substrate is for supporting a reaction field for the amplification reaction to take place, formed by the existence of the above-described reaction mixture. The substrate comprises, on a surface thereof, an electrode for detecting an electric signal from a redox probe. The electrode is disposed so as to form the reaction field on itself. Such a substrate may be, for example, the one shown in
FIG. 2 . - When a substrate is contained in an assay kit, the composition ingredients of the reaction mixture may be releasably immobilized to the surface to be brought into contact with a reaction field of the substrate so as to be brought into the reaction field.
- For example, a reaction field may be formed from a reaction mixture containing the composition ingredients, existing on an electrode of the substrate. With use of the reaction field, it is possible to detect nucleic acid simply with high sensitivity.
- According to the embodiment described above, there is provided an assay kit which can detect nucleic acid simply with high sensitivity.
- The behavior of the electric signal from RuHex in a LAMP amplification reaction was evaluated.
- Preparation of Substrate
- Thin films of titanium (500 nm) and gold (2000 nm) were formed on a surface of a Pyrex (registered trademark) glass plate (d=0.8 mm) by sputtering. Then, using a resist AZP4620, a gold electrode (φ=200 μm) was formed. After that, top of it was coated with mercaptohexanol.
- LAMP Amplification Reaction
- A reaction mixture was prepared, which contains an artificial sequence of parvo virus (105 copies, 1 μL) (listed in Table 1 as SEQ ID NO: 1) as an amplification product, an F3 primer (SEQ ID NO: 2), a B3 primer (SEQ ID NO: 3), an FIP primer (SEQ ID NO: 4), a BIP primer (SEQ ID NO: 5), an Lb primer (SEQ ID NO: 6) as a LAMP primer shown in Table 2, RuHex (25 microM) as a redox probe, KCl (60 mM), magnesium ion (8 mM), ammonium ion (10 mM), betaine (0.8 M), dNTPs (1.4 mM each) and polymerase (GspSSD) (8 units).
-
TABLE 1 VP gene of Parvo virus (SEQ ID NO: 1) AAACGCTAATACGACTCACTATAGGGCGATCTACGGGTACTTTCAATAAT CAGACGGAATTTAAATTTTTGGAAAACGGATGGGTGGAAATCACAGCAAA CTCAAGCAGACTTGTACATTTAAATATGCCAGAAAGTGAAAATTATAGAA GAGTGGTTGTAAATAATTTGGATAAAACTGCAGTTAACGGAAACATGGCT TTAGATGATACTCATGCACAAATTGTAACACCTTGGTCATTGGTTGATGC AAATGCTTGGGGAGTTTGGTTTAATCCAGGAGATTGGCAACTAATTGTTA ATACTATGAGTGAGTTGCATTTAGTTAGTTTTGAACAAGAAATTTTTAAT GTTGTTTTAAAGACTGTTTCAGAATCTGCTACTCAGCCACCAACTAAAGT TTATAATAATGATTTAACTGCATCATTGATGGTTGCATTAGATAGTAATA ATACTATGCCATTTACTCCAGCAGCTATGAGATCTGAGACATTGGGTTTT TATCCATGGAAACCAACCATACCAACTCCATGGAGATATTATTTTCAATG GGATAGAACATTAATACCATCTCATACTGGAACTAGTGGCACACCAACAA ATATATACCATGGTACAGATCCAGATGATGTTCAATTTTATACTATTGAA AATTCTGTGCCAGTACACTTACTAAGAACAGGTGATGAATTTGCTACAGG AACATTTTTTTTTGATTGTAAACCATGTAGACTAACACATACATGGCAAA CAAATAGAGCATTGGGCTTACCACCATTTCTAAATTCTTTGCCTCAAGCT GAAGGAGGTACTAACTTTGGTTATATAGGAGTTCAACAAGATAAAAGACG TGGTGTAACTCAAATGGGAAATACAAACTATATTACTGAAGCTACTATTA TGAGACCAGCTGAGGTTGGTTATAGTGCACCATATTATTCTTTTGAGGCG TCTACACAAGGGCCATTTAAAACACCCTTCCCTTTAGTGAGGGTTAATAA -
TABLE 2 SEQ ID No. Sequence 2 F3 GAGATATTATTTTCAATGGGATAGAAC 3 B3 CAATGCTCTATTTGTTTGCCATG 4 FIP GAACATCATCTGGATCTGTACCAACCATCTCATACTGGAACT AGTGGC 5 BIP CTGTGCCAGTACACTTACTAAGAGTGTTAGTCTACATGGTTT ACAATC 6 Lb ACAGGTGATGAATTTGCTACAGG - As a negative control, a sample was further prepared in which the artificial sequence of parvo virus was not added to the reaction mixture. The reaction mixture was brought onto the surface of the substrate having the electrode, and they were warmed isothermally at 67° C., to start the amplification reaction. As the amplification reaction proceeded, the electric signal was measured by a square wave voltammetry (SWV) method.
- The results are shown in
FIG. 6 .FIG. 6(a) is a graph showing the chronological variation in the reduction peak current in each of the case where there was zero copy of artificial sequence (SEQ ID NO: 1) of parvo virus and the case of 105 copies. In the case of 105 copies, the reduction peak current remarkably increased.FIG. 6(b) is a graph showing the chronological variation in the reduction peak potential in each of the case where there was zero copy of artificial sequence of parvo virus and the case of 105 copies. In the case of 105 copies, the reduction peak potential shifted. These results suggest that when an amplification product exists in the reaction mixture containing RuHex, the reduction peak current and the reduction peak potential increase. - The behavior of the electric signal from RuHex in the LAMP amplification was evaluated for reaction mixtures containing including different numbers of copies of the amplification product.
- Five reaction mixtures similar to that of Example 1 were prepared, which respectively contain zero copy, 102 copies, 103 copies, 104 copies and 105 copies of the artificial sequence (SEQ ID NO: 1) of parvo virus. With use of substrates similar to that of Example 1, these reaction mixtures were warmed isothermally at 67° C., to start the amplification reactions. As the amplification reactions proceeded, the electric signals were measured by the SWV method.
- The results were shown in
FIGS. 7 and 8 .FIGS. 7(a) to 7(e) are each a graph showing the chronological variation in the reduction peak potential in the reaction mixture containing the respective number of copies of the artificial sequence of parvo virus.FIGS. 8(f) to 8(i) are each a graphs showing the difference in amount of chronological variation in terms of the reduction peak potential betweenFIG. 7(a) and each ofFIGS. 7(b) to 7(e) . In each graph, an arrow indicates the time (potential rise time) when the variation amount of the peak reduction potential shifted by 1 mV/min or more. As the number of copies of parvo virus artificial sequence was greater, the potential rise time was shorter.FIG. 9 is a graph which plotted the potential rise time in each case of the respective numbers of copies of parvo virus artificial sequence, together with a calibration curve. The R2 value of the calibration curve was 0.9143. From these results, it was demonstrated that there is a correlation between the quantity of parvo virus artificial sequence existing and the potential rise time, thus suggesting that the quantity of amplification product in early stages of an amplification reaction can be determined (quantification) based on the potential rise time. - The relationship between the quantity of the redox probe, the current and the potential rise time was investigated.
- A reaction mixture having the same conditions as those of Example 1 except that it contained 1 mM of RuHex and another reaction mixture having the same conditions as that of Example 1 were prepared. With use of a substrate similar to that of Example 1 in the case of 105 copies, each of the reaction mixtures was warmed isothermally at 67° C., to start the amplification reaction. As the amplification reactions proceeded, the electric signals were measured by a linear sweep voltammetry (LSV) method (sweep rate: 0.1 V/s). The results are shown in
FIG. 10 . The variation amount of the reduction peak current was greater than that of the condition where RuHex was 25 μM (FIG. 6(a) ). Thus, it was suggested that when the concentration of the redox probe in the reaction mixture was 1 mM, the detection sensitivity was improved as compared to the case of 25 μM. If the concentration of RuHex was 3 mM or more, the amplification reaction was inhibited; therefore a preferable range is 25 μM to 3 mM. - The chronological variations of the current and potential rise time of reaction mixtures containing different numbers of copies of amplification product were investigated using an array electrode.
- Production of Chip
- Thin films of titanium (500 nm) and gold (2000 nm) were formed on a surface of a Pyrex (registered trademark) glass plate (d=0.8 mm) by sputtering. Then, using a resist AZP4620, sixty gold electrodes (active electrodes) (φ=200 μm) arranged in an array were formed. For every two active electrodes, a reference electrode and a counter electrode were formed to corresponding thereto. After that, top of it was coated with mercaptohexanol.
- LAMP Reaction
- Five reaction mixtures similar to that of Example 1 were prepared, which respectively contain zero copy, 102 copies, 103 copies, 104 copies and 105 copies of the artificial sequence (SEQ ID NO: 1) of parvo virus. These reaction mixtures were brought onto the surface of the substrate having electrodes, and they were warmed isothermally at 67° C., to start the amplification reactions. As the amplification reactions proceeded, the electric signals were measured by the LSV method (sweep rate: 0.5 V/s).
- The results are shown in
FIG. 11 .FIG. 11(a) is a graph showing the chronological variation in current value. As the number of copies of the artificial sequence of parvo virus was greater, the current rise time was shorter.FIG. 11(b) is a graph which plotted the current rise time in each case of the respective numbers of copies of parvo virus artificial sequence, together with a calibration curve. The R2 value of the calibration curve was 0.9071. From these results, it was demonstrated that there is a correlation between the quantity of parvo virus artificial sequence existing and the current rise time. Thus, it was suggested that with use of a substrate comprising electrodes arranged in an array, the quantity of amplification product in early stages of an amplification reaction can be determined (quantification) based on the potential rise time. - The chronological variations in peak current value of reaction mixtures containing different concentrations of magnesium were investigated. The reaction mixtures were prepared from the same ingredients as those of Example 1 except that they respectively contain 2.0 mM, 3.5 mM, 4 mM and 4.5 mM of magnesium ion, and 103 copies of the parvo virus artificial sequence (SEQ ID NO: 1) and RuHex (1 mM). Each of the reaction mixtures was brought onto the surface of a substrate such as of Example 1 having the electrode without application of mercaptohexanol, and was warmed isothermally at 65° C., to start the amplification reaction. As the amplification reactions proceeded, the electric signals were measured by the LSV method (sweep rate: 0.5 V/s).
- The results are shown in
FIG. 12 .FIG. 12 is a graph showing the chronological variation in relative value of the peak current value with respect to the peak current value before the starting of the amplification reaction start being set to a value of 1. In the reaction mixture having a magnesium ion concentration of 3.5 mM or lower, the current value decreased as the amplification reaction advanced. In the reaction mixture having a magnesium ion concentration of 4 mM or higher, the current value decreased once, and then increased. In the case where the magnesium ion concentration was 4.5 mM, the current rise time was shorter than the case of 4 mM, and the obtained current value itself was high. - Based on these results, it was suggested that when magnesium ion concentration was 4 or more mM, the amplified nucleic acid can be detected based on the increase in current value. Further, as the magnesium ion concentration was higher, the current value was higher. Therefore, it was estimated that RuHex bonded to the precipitate of magnesium pyrophosphate and condensed, and thus the RuHex concentration on the surface of the electrode increased, thereby raising the current value.
- The LAMP amplification reactions in reaction mixtures containing different concentrations of magnesium ion were investigated.
- The reaction mixtures were prepared from the same ingredients as those of Example 1 except that they respectively contain 2.0 mM to 12 mM of magnesium ion, and 103 copies of the parvo virus artificial sequence (SEQ ID NO: 1). 20 μL of each of the reaction mixtures was dispensed into a respective 0.2-mL tube, and warmed isothermally at 65° C., to start the amplification reaction. After 60 minutes of the amplification reaction in each mixture, the existence of the amplification product was examined by electrophoresis.
- The results are shown in Table 3. In the reaction mixture having a magnesium ion concentration of 4 mM or more, a typical rudder-shaped band was confirmed in the LAMP reaction.
- Based on these results, it was demonstrated that when the magnesium ion concentration was 4 mM or higher, the amplification product was produced by the LAMP reaction.
-
TABLE 3 MgSO4 Amplification (mM) (Presence of band in electrophoresis) 2 x 4 ∘ 6 ∘ 8 ∘ 10 ∘ 12 ∘ - While certain embodiments have been described, these embodiments have been presented by way of example only, and are not intended to limit the scope of the inventions. Indeed, the novel embodiments described herein may be embodied in a variety of other forms; furthermore, various omissions, substitutions and changes in the form of the embodiments described herein may be made without departing from the spirit of the inventions. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the inventions.
Claims (13)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/723,356 US20200109447A1 (en) | 2016-11-04 | 2019-12-20 | Nucleic acid detection method and assay kit |
| US17/649,568 US20220154261A1 (en) | 2016-11-04 | 2022-02-01 | Nucleic acid detection method and assay kit |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016216159A JP6346242B2 (en) | 2016-11-04 | 2016-11-04 | Nucleic acid detection method and assay kit |
| JP2016-216159 | 2016-11-04 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/723,356 Continuation US20200109447A1 (en) | 2016-11-04 | 2019-12-20 | Nucleic acid detection method and assay kit |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| US20180127814A1 true US20180127814A1 (en) | 2018-05-10 |
| US10557165B2 US10557165B2 (en) | 2020-02-11 |
Family
ID=62063688
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US15/691,337 Active 2037-12-27 US10557165B2 (en) | 2016-11-04 | 2017-08-30 | Nucleic acid detection method and assay kit |
| US16/723,356 Abandoned US20200109447A1 (en) | 2016-11-04 | 2019-12-20 | Nucleic acid detection method and assay kit |
| US17/649,568 Abandoned US20220154261A1 (en) | 2016-11-04 | 2022-02-01 | Nucleic acid detection method and assay kit |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/723,356 Abandoned US20200109447A1 (en) | 2016-11-04 | 2019-12-20 | Nucleic acid detection method and assay kit |
| US17/649,568 Abandoned US20220154261A1 (en) | 2016-11-04 | 2022-02-01 | Nucleic acid detection method and assay kit |
Country Status (2)
| Country | Link |
|---|---|
| US (3) | US10557165B2 (en) |
| JP (1) | JP6346242B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10865438B2 (en) | 2017-06-16 | 2020-12-15 | Kabushiki Kaisha Toshiba | Nucleic acid detection or quantification method, chip and assay kit therefor, device for detecting or quantifying nucleic acid and program therefor |
| US10975433B2 (en) | 2017-07-11 | 2021-04-13 | Kabushiki Kaisha Toshiba | Short-chain nucleic acid elongation primer set, assay kit, and short-chain nucleic acid elongation, amplification and detection methods |
| US11353418B2 (en) | 2018-03-13 | 2022-06-07 | Kabushiki Kaisha Toshiba | Nucleic acid reaction tool, nucleic acid detection/quantification kit, and nucleic acid detection/quantification method |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6346242B2 (en) | 2016-11-04 | 2018-06-20 | 株式会社東芝 | Nucleic acid detection method and assay kit |
| JP6559838B2 (en) * | 2018-05-22 | 2019-08-14 | 株式会社東芝 | Nucleic acid detection method and assay kit |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129632A1 (en) * | 2000-05-01 | 2003-07-10 | Yasuyoshi Mori | Method for detecting product of nucleic acid synthesizing reaction |
| US20040023258A1 (en) * | 2000-09-04 | 2004-02-05 | Fernando Patolsky | Method and system or detecting nucleic acids |
| US20070298415A1 (en) * | 2003-12-10 | 2007-12-27 | Takara Bio Inc. | Method of Amplifying Nucleic Acid |
| US8765373B2 (en) * | 2003-09-17 | 2014-07-01 | The Regents Of The University Of California | Sensor and method for detection of a target substance |
| US20160177387A1 (en) * | 2014-12-17 | 2016-06-23 | Universiti Brunei Darussalam | Novel electrochemical dna biosensor using graphene biochip for species identification |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040086892A1 (en) | 2002-11-06 | 2004-05-06 | Crothers Donald M. | Universal tag assay |
| US7258978B2 (en) | 2002-11-06 | 2007-08-21 | Geneohm Sciences | Electrochemical method to measure DNA attachment to an electrode surface in the presence of molecular oxygen |
| US20040086895A1 (en) | 2002-11-06 | 2004-05-06 | Crothers Donald M. | Method of electrochemical detection of somatic cell mutations |
| GB0428130D0 (en) | 2004-12-22 | 2005-01-26 | Oxford Biosensors Ltd | Selective HDL cholesterol assay |
| EP2662692A1 (en) * | 2012-05-11 | 2013-11-13 | Alacris Theranostics GmbH | Electrochemical detection of polymerase reactions by specific metal-phosphate complex formation |
| US20140220667A1 (en) | 2012-08-02 | 2014-08-07 | Mohammadali Safavieh | Device for pathogen detection |
| WO2014027580A1 (en) | 2012-08-17 | 2014-02-20 | 国立大学法人大阪大学 | Sample analysis method |
| JP6271076B2 (en) | 2015-02-27 | 2018-01-31 | 株式会社東芝 | Target nucleic acid detection method, assay kit, and probe immobilization substrate |
| JP6346242B2 (en) | 2016-11-04 | 2018-06-20 | 株式会社東芝 | Nucleic acid detection method and assay kit |
| JP6921638B2 (en) | 2017-06-16 | 2021-08-18 | 株式会社東芝 | Nucleic acid detection and quantification method, chip, assay kit, nucleic acid detection and quantification device and program |
-
2016
- 2016-11-04 JP JP2016216159A patent/JP6346242B2/en active Active
-
2017
- 2017-08-30 US US15/691,337 patent/US10557165B2/en active Active
-
2019
- 2019-12-20 US US16/723,356 patent/US20200109447A1/en not_active Abandoned
-
2022
- 2022-02-01 US US17/649,568 patent/US20220154261A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030129632A1 (en) * | 2000-05-01 | 2003-07-10 | Yasuyoshi Mori | Method for detecting product of nucleic acid synthesizing reaction |
| US20040023258A1 (en) * | 2000-09-04 | 2004-02-05 | Fernando Patolsky | Method and system or detecting nucleic acids |
| US8765373B2 (en) * | 2003-09-17 | 2014-07-01 | The Regents Of The University Of California | Sensor and method for detection of a target substance |
| US20070298415A1 (en) * | 2003-12-10 | 2007-12-27 | Takara Bio Inc. | Method of Amplifying Nucleic Acid |
| US20160177387A1 (en) * | 2014-12-17 | 2016-06-23 | Universiti Brunei Darussalam | Novel electrochemical dna biosensor using graphene biochip for species identification |
Non-Patent Citations (2)
| Title |
|---|
| Patolsky et al, Angew, Chemie Int. Ed., vol. 41, pages 3398-3402, 2002. * |
| Tomita et al, Nature Protocols, vol. 3, pages 877—882 and Corrigendum, published online 24 April 2008; corrected online 12 January 2012. * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10865438B2 (en) | 2017-06-16 | 2020-12-15 | Kabushiki Kaisha Toshiba | Nucleic acid detection or quantification method, chip and assay kit therefor, device for detecting or quantifying nucleic acid and program therefor |
| US11952620B2 (en) | 2017-06-16 | 2024-04-09 | Kabushiki Kaisha Toshiba | Nucleic acid detection or quantification method, chip and assay kit therefor, device for detecting or quantifying nucleic acid and program therefor |
| US10975433B2 (en) | 2017-07-11 | 2021-04-13 | Kabushiki Kaisha Toshiba | Short-chain nucleic acid elongation primer set, assay kit, and short-chain nucleic acid elongation, amplification and detection methods |
| US11655505B2 (en) | 2017-07-11 | 2023-05-23 | Kabushiki Kaisha Toshiba | Short-chain nucleic acid elongation primer set, assay kit, and short-chain nucleic acid elongation, amplification and detection methods |
| US11353418B2 (en) | 2018-03-13 | 2022-06-07 | Kabushiki Kaisha Toshiba | Nucleic acid reaction tool, nucleic acid detection/quantification kit, and nucleic acid detection/quantification method |
Also Published As
| Publication number | Publication date |
|---|---|
| US10557165B2 (en) | 2020-02-11 |
| US20220154261A1 (en) | 2022-05-19 |
| US20200109447A1 (en) | 2020-04-09 |
| JP6346242B2 (en) | 2018-06-20 |
| JP2018068258A (en) | 2018-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220154261A1 (en) | Nucleic acid detection method and assay kit | |
| US11952620B2 (en) | Nucleic acid detection or quantification method, chip and assay kit therefor, device for detecting or quantifying nucleic acid and program therefor | |
| US20170191122A1 (en) | Method of detecting target nucleic acid, assay kit and nucleic acid probe immobilized substrate | |
| US20140155289A1 (en) | Nucleic acid analysis method | |
| JP7392048B2 (en) | Analysis method and kit | |
| JP6559838B2 (en) | Nucleic acid detection method and assay kit | |
| WO2010030035A1 (en) | Impedance spectroscopy measurement of dna | |
| US20210214805A1 (en) | Analytical method and kit | |
| JP6862502B2 (en) | Nucleic acid detection method and assay kit | |
| WO2016077291A1 (en) | Isothermal amplification assay for the detection of short nucleic acid sequences | |
| KR102165841B1 (en) | Biomarker microRNA let-7b or microRNA-664a for diagnosing diabetes and use thereof | |
| US10876153B2 (en) | Nucleic acid detection method | |
| EP4079850A1 (en) | Analytical method and kit | |
| CN120555563A (en) | Nucleic acid detection using nanogap electrical sensors | |
| Wümpelmann et al. | Electric chips for rapid detection and quantification of nucleic acids M. Gabig-Ciminska"*", A. Holmgren", H. Andresen", K. Bundvig Barken" | |
| CN108531548A (en) | A kind of cell cDNA chip and its preparation method and application | |
| en Hohenlansberg | Telomerase Assays A review and comparison of several telomerase activity assays. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: KABUSHIKI KAISHA TOSHIBA, JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:HASHIMOTO, KOJI;ITO, KEIKO;INADA, MIKA;REEL/FRAME:043451/0724 Effective date: 20170817 |
|
| FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
| STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
| STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
| MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |